United States · FDA National Drug Code directory
Remifentanil Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-723_406a07e3-a3f8-4fef-901e-021d00743c40
- Product NDC
- 63323-723
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Remifentanil Hydrochloride
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180119
- Source listing expiry
- 20261231
Source-listed ingredients
- REMIFENTANIL HYDROCHLORIDE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-06) / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-04) · 63323-723-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →